Search Clinical Trials
597,367 trials
ID
Status
Phase
Title
Sponsor
NCT07752849
Palatoplasty Techniques Using PRF and Gentamicin-Loaded PRF in Cleft PalateAl-Thawra Modern General HospitalRecruitingNot Applicable
NCT07752849Recruiting
Not Applicable
Palatoplasty Techniques Using PRF and Gentamicin-Loaded PRF in Cleft PalateAl-Thawra Modern General...
NCT07753109
GARDENING ACTIVITIES, STRESS, AND SOCIAL INTERACTION IN COLLEGE STUDENTSAtaturk UniversityNot Yet RecruitingNot Applicable
NCT07753109Not Yet Recruiting
Not Applicable
GARDENING ACTIVITIES, STRESS, AND SOCIAL INTERACTION IN COLLEGE STUDENTSAtaturk University
NCT07752342
Exploring Wellbeing Outcomes in Adolescents Using Bifidobacterium Longum, 1714™: a Prospective Open-Label Real-World StudyNovonesisNot Yet RecruitingNot Applicable
NCT07752342Not Yet Recruiting
Not Applicable
Exploring Wellbeing Outcomes in Adolescents Using Bifidobacterium Longum, 1714™:...Novonesis
NCT07752693
The Effect Of Partner-Assısted Rebozo Technıque On Labor Paın And Satısfactıon In Prımary Pregnant WomenIstanbul Saglik Bilimleri UniversityRecruitingNot Applicable
NCT07752693Recruiting
Not Applicable
The Effect Of Partner-Assısted Rebozo Technıque On Labor Paın And Satısfactıon I...Istanbul Saglik Bilimleri...
NCT07751848
A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus ErythematosusAstraZenecaNot Yet RecruitingPhase 3
NCT07751848Not Yet Recruiting
Phase 3
A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active...AstraZeneca
NCT07751809
AI-ECG for Predicting CMR-Defined Myocardial Injury in Acute Myocardial InfarctionMedical AICompleted
NCT07751809Completed
—
AI-ECG for Predicting CMR-Defined Myocardial Injury in Acute Myocardial Infarcti...Medical AI
NCT07752043
Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Severe Sickle Cell Disease PatientsAssistance Publique - Hôpitaux de ParisNot Yet RecruitingNot Applicable
NCT07752043Not Yet Recruiting
Not Applicable
Standard of Care Comparative Arm of Phase 1/2 Gene Therapy Trial DREPAMIR" in Se...Assistance Publique - Hôp...
NCT07751198
Therapeutic Effects of Oat-based Porridge on Fetomaternal Outcomes Among Hypocalcemic Antenatal WomenUniversity of Lahore Hospital (ULH)CompletedNot Applicable
NCT07751198Completed
Not Applicable
Therapeutic Effects of Oat-based Porridge on Fetomaternal Outcomes Among Hypocal...University of Lahore Hosp...
NCT07751965
Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe ARCeric SàrlNot Yet RecruitingNot Applicable
NCT07751965Not Yet Recruiting
Not Applicable
Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in...Ceric Sàrl
NCT07751939
Artificial Intelligence Model to Predict Chronic Kidney Outcomes in a Vietnamese CohortUniversity Medical Center Ho Chi Minh City (UMC)Active Not Recruiting
NCT07751939Active Not Recruiting
—
Artificial Intelligence Model to Predict Chronic Kidney Outcomes in a Vietnamese...University Medical Center...
NCT07752719
APEX-STROKE CALM-ICH DomainBeijing University of Chinese MedicineNot Yet RecruitingPhase 3
NCT07752212
Comparative Assessment of Maxillary Canine Retraction With and Without PiezocisionFoundation University IslamabadCompletedNot Applicable
NCT07752212Completed
Not Applicable
Comparative Assessment of Maxillary Canine Retraction With and Without Piezocisi...Foundation University Isl...
NCT07752810
Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With GoutHangzhou Grand Biologic Pharmaceutical, Inc.CompletedPhase 1
NCT07752810Completed
Phase 1
Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patie...Hangzhou Grand Biologic P...
NCT07751887
Middle Meningeal Artery Embolisation in Chronic Subdural HematomaUniversity Hospital Hradec KraloveActive Not RecruitingNot Applicable
NCT07751887Active Not Recruiting
Not Applicable
Middle Meningeal Artery Embolisation in Chronic Subdural HematomaUniversity Hospital Hrade...
NCT07753356
VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSYMarcelo Ruben OlivaNot Yet Recruiting
NCT07753356Not Yet Recruiting
—
VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSYMarcelo Ruben Oliva
NCT07751874
A Prospective, Observational Study to Evaluate the Safety and Feasibility of Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation in a Cohort Critical Ill Patients With Acute Kidney Injury and Presumed Absent Citrate MetabolismUniversity Hospital, AntwerpNot Yet Recruiting
NCT07751874Not Yet Recruiting
—
A Prospective, Observational Study to Evaluate the Safety and Feasibility of Con...University Hospital, Antw...
NCT07751471
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 2
NCT07751471Not Yet Recruiting
Phase 2
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-0...Institute of Hematology &...
NCT07752576
Designing and Evaluating Multi-level Implementation Strategies to Address Alcohol Use Within Oncology CareNational Institutes of Health (NIH)Not Yet RecruitingNot Applicable
NCT07752576Not Yet Recruiting
Not Applicable
Designing and Evaluating Multi-level Implementation Strategies to Address Alcoho...National Institutes of He...
NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related ComorbiditiesAbbVieNot Yet RecruitingPhase 2
NCT07752979Not Yet Recruiting
Phase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight...AbbVie
NCT07753330
Efficacy of Expectancy Focused Exposure Therapy for Anxiety DisordersUniversidad de los Andes, ChileRecruitingNot Applicable
NCT07753330Recruiting
Not Applicable
Efficacy of Expectancy Focused Exposure Therapy for Anxiety DisordersUniversidad de los Andes,...
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Recruiting3 (15%)
Active, not recruiting2 (10%)
not_applicable11 (55%)
Not Specified4 (20%)
Phase 32 (10%)
Phase 22 (10%)
Phase 11 (5%)